• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 684-698 of 1,261 results

2009 Exhibit: EX2009 Declaration of Sayem Osman

Document IPR2023-00724, No. 2009 Exhibit - EX2009 Declaration of Sayem Osman (P.T.A.B. Jul. 6, 2023)

cite Cite Document

1030 Exhibit: Kim 2007

Document IPR2023-00724, No. 1030 Exhibit - Kim 2007 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

1079 Exhibit: NCT115

Document IPR2023-00724, No. 1079 Exhibit - NCT115 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

1046 Exhibit: Yun 2006

Document IPR2023-00724, No. 1046 Exhibit - Yun 2006 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

1062 Exhibit: Zarin 2011

Document IPR2023-00724, No. 1062 Exhibit - Zarin 2011 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

1036 Exhibit: Mojsov 1987

Document IPR2023-00724, No. 1036 Exhibit - Mojsov 1987 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

1072 Exhibit: US5164366

Document IPR2023-00724, No. 1072 Exhibit - US5164366 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

2004 Exhibit: EX2004 Miller, M, et al, “Low Viscosity Highly Concentrated Injectable...

Document IPR2023-00724, No. 2004 Exhibit - EX2004 Miller, M, et al, “Low Viscosity Highly Concentrated Injectable Nonaqueous Suspensions of Lysozyme Microparticles,” Langmuir, Author Manuscript 2...

cite Cite Document

1085 Exhibit: J Med Chem

Document IPR2023-00724, No. 1085 Exhibit - J Med Chem (P.T.A.B. Mar. 16, 2023)

cite Cite Document

2506 Exhibit: EX2506 Novo Nordisk, Financial report for the period 1 January 2021...

Document IPR2023-00724, No. 2506 Exhibit - EX2506 Novo Nordisk, Financial report for the period 1 January 2021 to 31 March 2021 May 5, 2021 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2387 Exhibit: EX2387 American Heart Association, “Cardiovascular Disease and D...

Document IPR2023-00724, No. 2387 Exhibit - EX2387 American Heart Association, “Cardiovascular Disease and Diabetes,” httpswwwheartorgenhealth topicsdiabetesdiabetes complications and riskscar...

cite Cite Document

2012 Exhibit: EX2012 Rossing, P, et al, “The rationale, design and baseline data of...

Document IPR2023-00724, No. 2012 Exhibit - EX2012 Rossing, P, et al, “The rationale, design and baseline data of FLOW, a kidney outcomes trial with once weekly semaglutide in people with type 2 diabe...

cite Cite Document

2089 Exhibit: EX2089 American Society for Preventive Cardiology, “Cardiometabol...

Document IPR2023-00724, No. 2089 Exhibit - EX2089 American Society for Preventive Cardiology, “Cardiometabolic Fellowship,” httpswwwaspconlineorgprofessional developmentcardiometabolic fellows...

cite Cite Document

2083 Exhibit: EX2083 V Aroda et al, “Efficacy and safety of once weekly semaglutid...

Document IPR2023-00724, No. 2083 Exhibit - EX2083 V Aroda et al, “Efficacy and safety of once weekly semaglutide versus once daily insulin glargine as add on to metformin with or without sulfonylureas...

cite Cite Document

2457 Exhibit: EX2457 Soliqua 10033 Prescribing Information rev Aug 2017

Document IPR2023-00724, No. 2457 Exhibit - EX2457 Soliqua 10033 Prescribing Information rev Aug 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
<< 1 2 3 4 5 ... 46 47 48 49 50 ... >>